JPMORGAN CHASE & CO - INSMED INC ownership

INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 35 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$428,845
-87.5%
431,000
-88.0%
0.00%
Q2 2023$3,421,049
+13.7%
3,603,000
+7.8%
0.00%
Q1 2023$3,008,000
+103911.1%
3,342,000
+7.0%
0.00%
Q4 2022$2,892
-99.9%
3,122,000
+40.3%
0.00%
Q3 2022$2,092,000
+286.7%
2,226,000
+279.2%
0.00%
Q2 2022$541,000
-88.9%
587,000
-87.9%
0.00%
-100.0%
Q1 2022$4,863,000
+124.5%
4,862,000
+131.0%
0.00%
Q4 2021$2,166,000
+104.9%
2,105,000
+106.2%
0.00%
Q3 2021$1,057,000
+81.3%
1,021,000
+95.6%
0.00%
Q1 2021$583,000
-71.4%
522,000
-70.8%
0.00%
Q4 2020$2,039,000
+367.7%
1,790,000
+297.8%
0.00%
Q4 2019$436,000450,0000.00%
Other shareholders
INSMED INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sycale Advisors (NY) LLC 8,065,000$9,173,0006.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 61,000,000$69,219,0001.37%
Sonora Investment Management, LLC 6,645,000$7,519,0000.62%
ZAZOVE ASSOCIATES LLC 4,377,000$4,951,0000.61%
ADVENT CAPITAL MANAGEMENT /DE/ 22,362,000$25,324,0000.54%
SSI INVESTMENT MANAGEMENT LLC 6,532,000$7,328,0000.52%
Context Capital Management, LLC 2,163,000$2,438,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 35,070,000$39,493,0000.29%
Cheyne Capital Management (UK) LLP 450,000$509,0000.26%
FARALLON CAPITAL MANAGEMENT LLC 32,500,000$36,552,0000.22%
View complete list of INSMED INC shareholders